Pharmacogenetic Cinical Decision Support Service for the Swiss healthcare market.

The projected PGCDSS service analyses the individual pharmacogenetic data and warns the physician in case of critical drug prescriptions.

Fiche signalétique

  • Département HESB | Technique et informatique
  • Pôle de recherche Mobilité de la société d'information
  • Champ de recherche Informatique médicale
  • Organisme de financement Gebert Rüf Stiftung
  • Durée (prévue) 01.09.2018 - 30.06.2020
  • Direction du projet Murat Sariyar
  • Mots-clés Pharmakogenetics, Clinical Decision Support, Medical Informatics, Spin-Off

Contexte initial

Pharmacogenetics is relevant for almost every physician prescribing drugs; the bandwidth of pharmacogenetically relevant drugs ranges from highly specialised anti-cancer medications to very common drugs like codeine. We will provide a PGCDSS that can easily be integrated with the different IT systems of the healthcare providers. Furthermore, our suggested solution can be seamlessly integrated into the physicians’ prescription workflow and thus has low adaptation costs.


The aim of our project is a release candidate of a pharmacogenetic clinical decision support service (PGCDSS).

Compétences clés

Genetics Pharmakogenetcs, Bioinformatics, Clinical Decision Support.